For Investors

Close

Incyte International Locations

NORTH AMERICA—
HEADQUARTERS

FINLAND

JAPAN

SWEDEN

EUROPE—
HEADQUARTERS

FRANCE

THE NETHERLANDS

SWITZERLAND

AUSTRIA

GERMANY

NORWAY

UNITED KINGDOM

DENMARK

ITALY

SPAIN

Home > 网络加速器

golink 加速器

golink 加速器

golink 加速器

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

golink 加速器

Upcoming

Monday August 3, 2023 at 8:00 AM EDT
Monjuvi (tafasitamab-cxix) FDA approval

Tuesday August 4, 2023 at 8:00 AM EDT
Q2 2023 Incyte Corporation Earnings Conference Call

golink 加速器

View All Events

手机网络加速器免费

Monday April 6, 2023 at 8:00 AM EDT
江苏一网吧为吸引学生上网 安装翻墙软件被查处_央广网 - cnr.cn:2021-12-9 · 网络安监员反电信诈骗:3年几乎没睡过几次好觉,数万元被骗、假冒淘宝客服、接警地浙江湖州、受害人是新手卖家，几条线索摆在眼前。诈骗过程很 ...

View All Events

Press Releases

网络加速器

FDA Approves Monjuvi® (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)


sub免费网络加速器

Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi®) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints


July 16, 2023

Incyte to Report Second Quarter Financial Results


View All Releases

golink 加速器

Michael Booth D.Phil
Division VP, Investor Relations & Corporate Responsibility
Phone: 302.498.5914
mbooth@incyte.com

Lauren Ayala, MBA
Senior Director, Investor Relations & Corporate Responsibility
Phone: 302.498.6141
layala@incyte.com

Christine Chiou
Senior Director, Investor Relations
Phone: 302.274.4773
cchiou@incyte.com

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Reports

免费全球加速器 网络加速器

Quarterly Reports

golink 加速器


All Press Releases

All Events

All SEC Filings